Preliminary estimate for the second-trimester maternal serum screening detection rate of the 45,X karyotype using α-fetoprotein, unconjugated estriol and human chorionic gonadotropin

References

• Hook EB. Prevalence, risks and recurrence. In Brock DJH, Rodeck CH, Ferguson-Smith MA, eds. Prenatal Diagnosis and Screening. Edinburgh, UK: Churchill Livingstone, 1992:351–92
   Google Scholar
• Hook EB, Warburton D. The distribution of chromosomal genotypes associated with Turner's syndrome: livebirth prevalence rates and evidence for diminished fetal morbidity and severity in genotypes associated with structural X abnormalities or mosaicism. Hum Genet 1983;64:24–7
   PubMed Web of Science ®Google Scholar
• Warburton D, Byrne J, Canki N. Chromosome Anomalies and Prenatal Development: An Atlas. Oxford, UK: Oxford University Press, 1991
   Google Scholar
• Lippe B. Turner syndrome. Endocrinol Metab Clin North Am 1991;20:121–52.
   PubMed Web of Science ®Google Scholar
• Salter DN, Canick JA, Schwartz S, et al. Multiple-marker screening in pregnancies with hydropic and non-hydropic Turner syndrome. Am J Obstet Gynecol 1992;67:1021–4
   Google Scholar
• Lambert-Messerlian GM, Salter DN Jr, Tumber MB, et al. Second-trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops. Prenat Diagn 1998;18: 1061–7
   Google Scholar
• Wenstrom KD, Boots LR, Cosper PC. Multiple marker screening test: identification of fetal cystic hygroma, hydrops and sex chromosome aneuploidy. J Matern Fetal Med 1996; 5:31–5
   Google Scholar
• Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotrophin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 1987;7:623–30
   Google Scholar
• Bogart MH, Golbus MS, Sorg ND, et al. Human chorionic gonadotropin levels in pregnancies with aneuploid fetuses. Prenat Diagn 1989;9:379–84
   PubMed Web of Science ®Google Scholar
• Crandall BF, Hanson FW, Keener S, et al. Maternal serum screening for a-fetoprotein, unconjugated estriol, and human chorionic gonadotropin between 11 and 15 weeks of preg-nancy to detect fetal chromosome abnormalities. Am J Obstet Gynecol 1993;168:1864–9
   PubMed Web of Science ®Google Scholar
• Burton BK, Prins GS, Verp MS. A prospective trial of prenatal screening for Down syndrome by means of a-fetoprotein, human chorionic gonadotropin, and unconjugated estriol. Am J Obstet Gynecol 1993;169:526–30
   Google Scholar
• Ruiz C, Lamm F, Hart PS. Turner syndrome and multiple-marker screening. Clin Chem 1999;45:2259–61
   Google Scholar
• Wald N, Hackshaw A. Tests using multiple markers. In Wald N, Leck I, eds. Antenatal and Neonatal Screening. Oxford, UK: Oxford University Press, 2000:23–57
   Google Scholar
• Larsen SO, Christiansen M, Norgaard-Pedersen B. Calcula-tion of roc curves in multidimensional likelihood ratio based screening with Down's syndrome as a special case. J Med Screen 1998;5:57–62
   Google Scholar
• Benn PA, Ying J, Beazoglou T, et al. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results. Prenat Diagn 2001;21:46–51
   PubMed Web of Science ®Google Scholar
• Wald NJ, Densem JW, Smith D, et al. Four-marker serum screening for Down's syndrome. Prenat Diagn 1994;14:707-16 Bray I, Wright DE, Davies C, et al. Joint estimation of Down syndrome risk and ascertainment rates: a meta-analysis of nine published data sets. Prenat Diagn 1998;18: 9–20
   Google Scholar
• Bray I, Wright DE, Davies C, et al. Joint estimation of Down syndrome risk and ascertainment rates: a meta-analysis of nine published data sets. Prenat Diagn 1998;18:9�20
   Web of Science ®Google Scholar
• Palomaki GE, Haddow JE, Knight GJ, et al. Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin. Prenat Diagn 1995;15:713–23
   PubMed Web of Science ®Google Scholar
• National Center for Health Statistics. 1999 Natality Data Set. Hyattsville, MD. CD-ROM series 21; no. 12; May 2001
   Google Scholar
• Ferguson-Smith MA, Yates JRW. Maternal age specific rates for chromosome aberrations and factors influencing them: report of a collaborative European study on 52 965 amniocenteses. Prenat Diagn 1984;45: 5–44
   Google Scholar
• Gravholt CH, Juul S, Naeraa RW, et al. Prenatal and postnatal prevalence of Turner's syndrome: a registry study. Br Med J 1996;312:16–21
   PubMed Web of Science ®Google Scholar
• Carothers AD, Frackiewicz A, De Mey R, et al. A collaborative study of the aetiology of Turner syndrome. Ann Hum Genet 1980;43:355–68
   PubMed Web of Science ®Google Scholar
• Saller DN, Canick JA, Oyer CE. The detection of non-immune hydrops through second-trimester maternal serum screening. Prenat Diagn 1996;16:431–5
   Google Scholar
• Marchase C, Savin E, Dragone E, et al. Cystic hygroma: prenatal diagnosis and counseling. Prenat Diagn 1985;5: 221–7
   PubMed Web of Science ®Google Scholar